The global mRNA Therapeutics Market, valued at USD 40.0 billion in 2023, is anticipated to grow to USD 46.5 billion by 2032, at a compound annual growth rate (CAGR) of 1.7% from 2024 to 2032. The market's growth is primarily driven by the increasing applications of mRNA technology in vaccines and other therapeutic areas, advancements in scientific research,...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian